Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • PHARMACEUTICAL PROD DEV INC Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY2004
    Assets
    Cash and Short Term Investments 518.82 M 502.38 M 435.67 M 319.82 M 249.37 M
    Net Receivables 401.30 M 481.99 M 409.43 M 303.40 M 271.39 M
    Total Inventories 19.70 M 18.12 M 13.49 M 15.78 M 17.25 M
    Progress Payments & Others 0.00 0.00 0.00 0.00 0.00
    Prepaid Expenses 27.24 M 32.45 M — — —
    Other Current Assets 52.14 M 70.72 M 49.61 M 11.44 M 37.06 M
    Current Assets Total 1.02 B 1.07 B 908.20 M 682.88 M 575.06 M
    Long Term Receivables 0.00 0.00 0.00 0.00 0.00
    Investment in Unconsolidated Subsidiaries 0.00 15.66 M — — —
    Other Investments 101.65 M 7.73 M 22.48 M 33.17 M 66.66 M
    Property, Plant & Equipment Net 385.79 M 356.19 M 323.54 M 210.02 M 136.50 M
    Property, Plant & Equipment Gross 673.77 M 606.34 M 522.45 M 363.80 M 260.68 M
    Accumulated Depreciation 287.98 M 250.15 M 198.91 M 153.78 M 124.18 M
    Other Assets 229.45 M 219.87 M 215.98 M 213.44 M 184.60 M
    Deferred Charges — — — — —
    Tangible Other Assets 2.64 M 2.55 M 1.58 M 1.79 M 929,000.00
    Intangible Other Assets 226.82 M 217.32 M 214.40 M 211.66 M 183.68 M
    Total Assets 1.74 B 1.67 B 1.47 B 1.14 B 962.83 M
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 0.00 0.00 75.16 M 1.61 M 599,000.00
    Accrued Payroll 100.92 M 91.22 M 87.44 M 73.38 M 59.17 M
    Income Taxes Payable 18.39 M 16.28 M 16.65 M 18.18 M 5.89 M
    Dividends Payable 0.00 0.00 0.00 0.00 —
    Other Current Liabilities 364.03 M 340.75 M 301.01 M 251.71 M 239.44 M
    Current Liabilities Total 506.36 M 473.23 M 495.49 M 355.25 M 317.96 M
    Long Term Debt 0.00 0.00 0.00 22.70 M 6.37 M
    Provision for Risks & Charges 34.61 M 9.76 M 10.77 M 11.15 M 9.92 M
    Deferred Taxes -16.35 M -7.90 M -7.12 M -9.43 M -12.00 M
    Deferred Income 15.87 M 47.47 M 18.16 M 17.64 M 5.27 M
    Deferred Tax Liability in Untaxed Reserves — — — — —
    Other Liabilities 14.61 M 0.00 0.00 0.00 0.00
    Total Liabilities 555.10 M 522.56 M 517.30 M 397.30 M 327.52 M
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 —
    Minority Interest 0.00 0.00 0.00 0.00 0.00
    Preferred Stock 0.00 0.00 0.00 0.00 0.00
    Common Equity 1.18 B 1.15 B 952.90 M 742.22 M 635.31 M
    Common Stock 5.88 M 5.96 M 5.88 M 5.80 M 5.66 M
    Capital Surplus 544.89 M 502.90 M 449.17 M 340.45 M 293.20 M
    Revaluation Reserves 0.00 0.00 0.00 0.00 —
    Other Appropriated Reserves -12.08 M -7.24 M -7.76 M -10.43 M -5.75 M
    Unappropriated (Free) Reserves 0.00 0.00 0.00 0.00 —
    Retained Earnings 684.77 M 626.02 M 490.76 M 396.07 M 325.27 M
    Equity in Untaxed Reserves — — — — —
    ESOP Guarantees 0.00 0.00 0.00 0.00 —
    Unrealized Foreign Exchange Gain (Loss) -22.73 M 23.39 M 14.49 M 4.23 M 14.90 M
    Unrealized Gain (Loss) on Marketable Securities -19.73 M -939,000.00 357,000.00 6.10 M 2.03 M
    Treasury Stock 0.00 0.00 0.00 0.00 0.00
    Total Liabilities & Shareholders Equity 1.74 B 1.67 B 1.47 B 1.14 B 962.83 M
    Common Shares Outstanding 117.63 M 119.10 M 117.62 M 116.00 M 113.24 M